Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer: a randomised controlled trial

This publication has 18 references indexed in Scilit:

• BICALUTAMIDE 150 MG IN ADDITION TO STANDARD CARE IN PATIENTS WITH LOCALIZED OR LOCALLY ADVANCED PROSTATE CANCER: RESULTS FROM THE SECOND ANALYSIS OF THE EARLY PROSTATE CANCER PROGRAM AT MEDIAN FOLLOWUP OF 5.4 YEARS
  Journal of Urology, 2004
• Gynecomastia Due to Hormone Therapy for Advanced Prostate Cancer: A Report of Ten Surgically Treated Cases and a Review of Treatment Options
  Tumori Journal, 2004
• The safety and tolerability of low-dose irradiation for the management of gynaecomastia caused by antiandrogen monotherapy
  The Lancet Oncology, 2003
• The Prostate Cancer Continuum: The Role of Bicalutamide (CasodexR)
  The Prostate Journal, 2001
• Rising PSA after a Radical Treatment
  European Urology, 2001
• Gynecomastia in patients with prostate cancer: a review of treatment options
  Urology, 2000
• BICALUTAMIDE MONOTHERAPY COMPARED WITH CASTRATION IN PATIENTS WITH NONMETASTATIC LOCALLY ADVANCED PROSTATE CANCER: 6.3 YEARS OF FOLLOWUP
  Journal of Urology, 2000
• LONG-TERM HAZARD OF PROGRESSION AFTER RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED PROSTATE CANCER: CONTINUED RISK OF BIOCHEMICAL FAILURE AFTER 5 YEARS
  Journal of Urology, 2000
• Bicalutamide Monotherapy Versus Flutamide Plus Goserelin in Prostate Cancer Patients: Results of an Italian Prostate Cancer Project Study
  Journal of Clinical Oncology, 1999
• The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
  JNCI Journal of the National Cancer Institute, 1993